3-hydroxyflavone has been researched along with Atherosclerosis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (35.29) | 29.6817 |
| 2010's | 9 (52.94) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, S; Jin, R; Li, X; Tan, L; Tong, H; Zhang, X | 1 |
| Chen, L; Deng, X; Deng, Y; He, G; He, J; Jiang, P; Kuang, D; Li, J; Li, R; Luo, J; Luo, S; Tan, S; Yan, M; Yang, D; Yang, Z; Yuan, Q; Zhou, Y; Zou, Y | 1 |
| Chen, X; Liu, TT; Tang, K; Xu, XL; Zeng, Y; Zhang, W | 1 |
| Dong, X; Lu, S; Luo, Y; Sun, G; Sun, X; Xu, L | 1 |
| Peng, Y; Tang, K; Wang, YQ; Wei, XY; Xu, XL; Zeng, Y; Zhao, ZY | 1 |
| Patel, R; Singh, RP; Varghese, JF; Yadav, UCS | 1 |
| Hodgson, JM; Ivey, KL; Lewis, JR; Prince, RL | 1 |
| Calabriso, N; Carluccio, MA; Giovinazzo, G; Ingrosso, I; Massaro, M; Pellegrino, M; Scoditti, E; Storelli, C | 1 |
| Best Sampson, JN; Henning, AL; Hill, DW; McFarlin, BK; Prado, EA; Venable, AS; Vingren, JL | 1 |
| Davies, TS; Garaiova, I; Michael, DR; Moss, JW; Plummer, SF; Ramji, DP | 1 |
| Cocchi, CA; Gershwin, ME; Keen, CL; Lanfredini, M; Selmi, C | 1 |
| Bernaert, H; Corti, R; Ferri, C; Heptinstall, S; Molinari, E; Paoletti, R; Poli, A; Serafini, M; Smit, HJ; Vinson, JA; Violi, F; Visioli, F | 1 |
| Schewe, T; Sies, H | 1 |
| Caspi, A; Gorinstein, S; Jastrzebski, Z; Katrich, E; Leontowicz, H; Leontowicz, M; Libman, I; Tashma, Z; Trakhtenberg, S | 1 |
| Ghaffari, MA; Mojab, S | 1 |
3 review(s) available for 3-hydroxyflavone and Atherosclerosis
| Article | Year |
|---|---|
Multitarget and promising role of dihydromyricetin in the treatment of metabolic diseases.
Topics: Animals; Atherosclerosis; Diabetes Mellitus; Flavonols; Gene Expression Regulation; Humans; Hypoglycemic Agents; Metabolic Diseases; Non-alcoholic Fatty Liver Disease; Osteoporosis; Signal Transduction | 2020 |
Chocolate at heart: the anti-inflammatory impact of cocoa flavanols.
Topics: Animals; Anti-Inflammatory Agents; Atherosclerosis; Blood Pressure; Cacao; Catechin; Cytokines; Female; Flavonols; Humans; Inflammation; Male; Microcirculation; NF-kappa B; Platelet Activation; Transcription Factors | 2008 |
Chocolate, lifestyle, and health.
Topics: Antioxidants; Atherosclerosis; Cacao; Diet; Dietary Sucrose; Energy Intake; Flavonoids; Flavonols; Food Handling; Food Preferences; Health Promotion; Health Status; Humans; Inflammation; Leukocytes; Life Style; Phenols; Polyphenols; Substance-Related Disorders | 2009 |
2 trial(s) available for 3-hydroxyflavone and Atherosclerosis
| Article | Year |
|---|---|
Natural cocoa consumption: Potential to reduce atherogenic factors?
Topics: Absorptiometry, Photon; Adult; Atherosclerosis; Biomarkers; Blood Glucose; Body Mass Index; Cacao; Candy; Cell-Derived Microparticles; Cholesterol, HDL; Cross-Over Studies; Diet; Double-Blind Method; Female; Flavonols; Haptoglobins; Humans; L-Selectin; Lipoproteins, HDL; Monocytes; Obesity; Overweight; Young Adult | 2015 |
Bioactivity of beer and its influence on human metabolism.
Topics: Adult; Aged; Antioxidants; Atherosclerosis; Beer; Blood Coagulation; Coronary Artery Bypass; Flavonoids; Flavonols; Humans; Lipids; Male; Middle Aged; Phenols; Polyphenols; Postoperative Period; Serum Albumin | 2007 |
12 other study(ies) available for 3-hydroxyflavone and Atherosclerosis
| Article | Year |
|---|---|
Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA-21 in apolipoprotein E-deficient mice.
Topics: Amidohydrolases; Animals; Apolipoproteins E; Arginine; Atherosclerosis; Enzyme Activation; Flavonols; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Lipid Metabolism; Lipids; Liver; Male; Mice, Inbred C57BL; MicroRNAs; Nitric Oxide; Nitric Oxide Synthase Type III; Signal Transduction | 2020 |
Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Aorta; Aortic Diseases; Atherosclerosis; Cytokines; Diet, High-Fat; Disease Models, Animal; Flavonols; Foam Cells; Genetic Predisposition to Disease; Human Umbilical Vein Endothelial Cells; Humans; Inflammation Mediators; Lipoproteins, LDL; Liver; Male; Mice; Mice, Knockout; Oxidative Stress; Phenotype; Plaque, Atherosclerotic; RAW 264.7 Cells; Receptors, LDL | 2017 |
Dihydromyricetin protects human umbilical vein endothelial cells from injury through ERK and Akt mediated Nrf2/HO-1 signaling pathway.
Topics: Apoptosis; Atherosclerosis; Cell Survival; Flavonols; Flow Cytometry; Heme Oxygenase-1; Human Umbilical Vein Endothelial Cells; Humans; MAP Kinase Signaling System; NF-E2-Related Factor 2; Oncogene Protein v-akt; Oxidative Stress; Protective Agents; Reactive Oxygen Species; Signal Transduction | 2017 |
Dihydromyricetin ameliorates foam cell formation via LXRα-ABCA1/ABCG1-dependent cholesterol efflux in macrophages.
Topics: Animals; Atherosclerosis; ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; Cholesterol; Dose-Response Relationship, Drug; Flavonols; Foam Cells; Humans; Liver X Receptors; Macrophages; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; THP-1 Cells | 2018 |
Induction of endothelial dysfunction by oxidized low-density lipoproteins via downregulation of Erk-5/Mef2c/KLF2 signaling: Amelioration by fisetin.
Topics: Atherosclerosis; Cells, Cultured; Flavonoids; Flavonols; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Inflammation; Kruppel-Like Transcription Factors; Lipoproteins, LDL; MEF2 Transcription Factors; Mitogen-Activated Protein Kinase 7; Monocytes; Nitric Oxide Synthase Type III; Protective Agents; Signal Transduction | 2019 |
Tea and non-tea flavonol intakes in relation to atherosclerotic vascular disease mortality in older women.
Topics: Aged; Aged, 80 and over; Atherosclerosis; Camellia sinensis; Diet; Feeding Behavior; Female; Flavonols; Follow-Up Studies; Humans; Odds Ratio; Phytotherapy; Plant Extracts; Risk; Western Australia | 2013 |
Multiple anti-inflammatory and anti-atherosclerotic properties of red wine polyphenolic extracts: differential role of hydroxycinnamic acids, flavonols and stilbenes on endothelial inflammatory gene expression.
Topics: Anti-Inflammatory Agents; Atherosclerosis; Cell Adhesion; Chemokine CCL2; Coumaric Acids; E-Selectin; Endothelial Cells; Flavonols; Humans; Inflammation; Intercellular Adhesion Molecule-1; Italy; NF-kappa B; Oxidative Stress; Polyphenols; RNA, Messenger; Stilbenes; Transcription Factor AP-1; Vascular Cell Adhesion Molecule-1; Wine | 2016 |
A Unique Combination of Nutritionally Active Ingredients Can Prevent Several Key Processes Associated with Atherosclerosis In Vitro.
Topics: Animals; Atherosclerosis; Biological Transport; Cell Line, Tumor; Cell Movement; Chemokine CCL2; Cholesterol; Dietary Supplements; Drug Interactions; Fatty Acids, Omega-3; Flavonols; Gene Expression Regulation; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Macrophages; Mice; Monocytes; Phenotype; Phytosterols; RNA, Messenger | 2016 |
Cocoa reduces inflammation associated with heart disease.
Topics: Aged; Antioxidants; Atherosclerosis; Cacao; Female; Flavonols; Health Knowledge, Attitudes, Practice; Humans; Inflammation; Male; Middle Aged; Platelet Activation | 2010 |
Myeloperoxidase-induced lipid peroxidation of LDL in the presence of nitrite. Protection by cocoa flavanols.
Topics: Atherosclerosis; Cacao; Flavonols; Humans; Lipid Peroxidation; Lipoproteins, LDL; Nitrites; Peroxidase | 2005 |
Influence of flavonols as in vitro on low density lipoprotein glycation.
Topics: Adult; Antioxidants; Atherosclerosis; Diabetic Angiopathies; Flavonoids; Flavonols; Glycation End Products, Advanced; Glycosylation; Humans; In Vitro Techniques; Kaempferols; Lipoproteins, LDL; Male; Quercetin; Rutin | 2007 |
The devil in the dark chocolate.
Topics: Atherosclerosis; Cacao; Candy; Energy Intake; Flavonols; Humans | 2007 |